Abstract
Drug manufacturers that are signed up to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) will see their tax rates increase by more than 11 percentage points in 2023, the government has said. The new rate, confirmed on 15 December 2022, means that manufacturers will need to pay the government 26.5% of their […]
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have